Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Jarius

Showing results (41-50 of 182) with videos related to

Pageof 19
Sort By:
Nature Clinical Practice. Neurology|March 13, 2008
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis opticaSven Jarius, Friedemann Paul, Diego Franciotta, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2015
Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosisJürgen Haas, Alexander Schwarz, Mirjam Korporal-Kunke, et al.
Journal of Neuroinflammation|July 30, 2022
Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literatureSven Jarius, Stefan Bräuninger, Ha-Yeun Chung, et al.
Plos One|May 13, 2016
Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple SclerosisMona Laible, Sven Jarius, Friedericke Mackensen, et al.
Neurology|June 11, 2017
Failure of alemtuzumab therapy to control MOG encephalomyelitisBrigitte Wildemann, Sven Jarius, Alexander Schwarz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive caseSven Jarius, Imke Metz, Fatima Barbara König, et al.
Journal of the Neurological Sciences|October 10, 2017
Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patientsMelissa Bouzar, Smail Daoudi, Samira Hattab, et al.
BMC Neurology|December 18, 2014
Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumabJens Harmel, Marius Ringelstein, Jens Ingwersen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2017
Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based studyNasrin Asgari, Sven Jarius, Helle Laustrup, et al.
Case Reports in Neurological Medicine|March 6, 2019
Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG-Positive PatientSeyed Hamidreza Mohseni, Hanne Pernille Bro Skejoe, Jens Wuerfel, et al.
Pageof 19

Showing results (41-50 of 182) with videos related to

Sort By:
Pageof 19
Nature Clinical Practice. Neurology|March 13, 2008
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis opticaSven Jarius, Friedemann Paul, Diego Franciotta, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2015
Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosisJürgen Haas, Alexander Schwarz, Mirjam Korporal-Kunke, et al.
Journal of Neuroinflammation|July 30, 2022
Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literatureSven Jarius, Stefan Bräuninger, Ha-Yeun Chung, et al.
Plos One|May 13, 2016
Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple SclerosisMona Laible, Sven Jarius, Friedericke Mackensen, et al.
Neurology|June 11, 2017
Failure of alemtuzumab therapy to control MOG encephalomyelitisBrigitte Wildemann, Sven Jarius, Alexander Schwarz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive caseSven Jarius, Imke Metz, Fatima Barbara König, et al.
Journal of the Neurological Sciences|October 10, 2017
Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patientsMelissa Bouzar, Smail Daoudi, Samira Hattab, et al.
BMC Neurology|December 18, 2014
Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumabJens Harmel, Marius Ringelstein, Jens Ingwersen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2017
Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based studyNasrin Asgari, Sven Jarius, Helle Laustrup, et al.
Case Reports in Neurological Medicine|March 6, 2019
Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG-Positive PatientSeyed Hamidreza Mohseni, Hanne Pernille Bro Skejoe, Jens Wuerfel, et al.
Pageof 19